Farms.com Home   Farm Equipment News

Art's Way Announces 'Mutual Separation Agreement' with David King

Art's-Way Manufacturing Co. Inc. announced that effective October 1, 2024 the company reached a mutual separation agreement with President David King. Current Chairman of the Board Marc McConnell will serve as president moving forward and the company will realize a net overhead reduction. McConnell has served on Art's Way's Board of Directors since 2001, served as Vice Chairman from January 2008 to April 2015 and has since served as Art's Way's Chairman of the Board.

King took over as president in March 2020, replacing Carrie Gunnerson, who served as CEO since 2007. 

On Oct. 4, Art's Way announced its third quarter consolidated corporate sales were down 27.6% and sales for the first 9 months were down 21.8%. 

Click here to see more...

Trending Video

New Solution Powers Efficient Pork Growth

Video: New Solution Powers Efficient Pork Growth


Alltech has introduced Olerix, an innovative phytogenic blend created to promote growth and feed efficiency in pigs. Through a proprietary coating process, the bioactive blend of phytogenic compounds used in Olerix is designed to outlast the manufacturing process, ensuring consistent outcomes from feed to finish. The result is a high-impact efficiency solution that provides consistent support for gut health, feed efficiency, immune function and growth performance. Olerix is backed by validated trials conducted under modern pork production conditions.

“As the industry searches for technology to drive profitability forward in a more sustainable manner, we’re thrilled to join that effort with our Olerix technology,” said Mark Hulsebus, general manager for U.S. pork at Alltech. “Our work in this phytogenic space is yielding very encouraging results, and we’re excited to make this new opportunity available to pork producers focused on optimizing feed efficiency and growth rates.”

“Olerix represents the next generation of phytogenic technology — combining feed efficiency, livability and immune support into a practical commercial solution producers can implement today,” said Andy Rash, U.S. monogastric director at Alltech.